Daridorexant for Insomnia and Alcoholism

(DIAS Trial)

RC
Overseen ByResearch Coordinator
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Sterling McPherson
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to see if a sleep medication, daridorexant (DTX), can help decrease drinking in people who have alcohol use disorder (AUD) and insomnia.

The main questions it aims to answer are:

* Can DTX decrease alcohol use in individuals with insomnia better than placebo?

* Can DTX increase sleep time and other sleep related outcomes better than placebo?

Participants will:

* Take prescribed medication (DTX or Placebo based on which group they are randomized to).

* Provide urine, breath, saliva, and blood samples.

* Come in for bi-weekly (once every 2 weeks) in-person visits.

* Answer questionnaires and surveys related to sleep, substance use, and physical/mental health.

* Use an EEG headband to track brain activity at night.

* Come in for 3 follow up visits one month, six months, and one year after treatment.

Are You a Good Fit for This Trial?

This trial is for adults who have both insomnia and alcohol use disorder. Participants should be willing to take medication, attend regular study visits, provide biological samples, and complete surveys about their sleep and drinking habits.

Inclusion Criteria

I am 18 years old or older.
DSM-5 diagnosis of AUD
Ability to read and speak English
See 7 more

Exclusion Criteria

Current DSM-5 diagnosis of severe substance use disorder not currently treated, other than nicotine
History of narcolepsy or complex sleep behaviors with sedative-hypnotics
Any other medical or psychiatric condition determined by medical team to compromise safe participation
See 4 more

What Are the Treatments Tested in This Trial?

Interventions

  • Daridorexant

Trial Overview

The study compares the effects of daridorexant (a sleep medication) versus a placebo on reducing alcohol use and improving sleep in people with insomnia and alcohol use disorder. All participants also receive brief counseling and support to help them stick to taking their medication.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: DaridorexantExperimental Treatment4 Interventions
Group II: PlaceboPlacebo Group4 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Sterling McPherson

Lead Sponsor

University of Kentucky

Collaborator

Trials
198
Recruited
224,000+

University of Mississippi Medical Center

Collaborator

Trials
185
Recruited
200,000+